skip to main content
Main Site Navigation
Top of main content

Clinical Trials Details

AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management (DECIDE)

Location: Carle - Heart & Vascular Institute
Body site or condition: Cardiovascular
Department: Cardiology

CP-910-001

The objective of HeartFlow's DECIDE Registry is to collect observational data about the management of patients before and after HeartFlow Artificial Intelligence-Quantitative Coronary Plaque Analysis (AI-QCPA).

Apply Now